Russell Skibsted serves as Executive at AEOLUS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Russell Skibsted has executed 11 insider transactions totaling $15.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 26, 2023 involved receiving (via award) 58,000 shares valued at $0.
Russell Skibsted currently holds 75,500 shares of AEOLUS PHARMACEUTICALS, INC. (AOLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Russell Skibsted has been a net buyer of AOLS stock. They have purchased $15.4K and sold $0 worth of shares.
Russell Skibsted's most recent insider trade was on Mar 26, 2023, when they sold 58,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 18, 2018 | BTX | $8.0K | Payment | 7,781 | $1.03 | Discretionary |
| Dec 18, 2018 | BTX | $0 | Option Exercise | 22,500 | $N/A | Discretionary |
| Oct 4, 2018 | BTX | $0 | Option Exercise | 11,250 | $N/A | Discretionary |
| Oct 4, 2018 | BTX | $8.6K | Payment | 3,891 | $2.22 | Discretionary |
| Aug 23, 2017 | BTX | $5.3K | Purchase | 2,000 | $2.64 | Discretionary |
| May 23, 2012 | AOLS | $1.7K | Purchase | 7,027 | $0.24 | Discretionary |
| May 18, 2011 | AOLS | $2.0K | Purchase | 5,000 | $0.41 | Discretionary |
| May 18, 2011 | AOLS | $2.1K | Purchase | 5,000 | $0.42 | Discretionary |
| May 18, 2011 | AOLS | $4.3K | Purchase | 10,000 | $0.43 | Discretionary |